Cryptenamine
Back to search| Scientific Name: | Cryptenamine |
| Brand Name: | Not Available |
| Company Owner: | Medpointe pharmaceuticals medpointe healthcare inc |
| Mechanism Of Action | Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism of action is not known. Some evidence has suggested that cryptenamine acts in a similar fashion to atropine, which lowers the “rest and digest” activity of all muscles and glands regulated by the parasympathetic nervous system. This occurs because atropine is a competitive inhibitor of the muscarinic acetylcholine receptors (acetylcholine is the neurotransmitter used by the parasympathetic nervous system) . Therefore muscarinic acetylcholine receptors will be listed as experimental targets for cryptenamine. |
| Description of the Drug: | Not Available |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00785
